Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Afd Pharmacoepi & Clinical Pharmacology"'
Autor:
Wittermans, Esther, van der Zee, Philip A, Qi, Hongchao, van de Garde, Ewoudt M W, Blum, Claudine A, Christ-Crain, Mirjam, Gommers, Diederik, Grutters, Jan C, Voorn, G Paul, Bos, Willem Jan W, Endeman, Henrik, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
ERJ Open Research, 8(1):00489-2021. European Respiratory Society
ERJ Open Research, 8(1). EUROPEAN RESPIRATORY SOC JOURNALS LTD
ERJ Open Research, 8(1), 1. European Respiratory Society
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research, 8(1). EUROPEAN RESPIRATORY SOC JOURNALS LTD
ERJ Open Research, 8(1), 1. European Respiratory Society
ERJ Open Research
article-version (VoR) Version of Record
Background Latent class analysis (LCA) has identified subgroups with meaningful treatment implications in acute respiratory distress syndrome. We performed a secondary analysis of three studies to assess whether LCA can identify clinically distinct s
Autor:
Bultink, Irene E M, de Vries, Frank, van Vollenhoven, Ronald F, Lalmohamed, Arief, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Rheumatology (Oxford, England)
Bultink, IEM, de Vries, F, van Vollenhoven, RF & Lalmohamed, A 2020, ' Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls ', Rheumatology (Oxford, England), vol. 60, pp. 207-216 . https://doi.org/10.1093/rheumatologt/keaa267
Rheumatology (United Kingdom), 60(1), 207-216. Oxford University Press
Rheumatology (Oxford, England), 60, 207-216. Oxford University Press
Rheumatology, 60(1), 207-216. Oxford University Press
Rheumatology (Oxford, England), 60(1), 207. Oxford University Press
Bultink, I E M, de Vries, F, van Vollenhoven, R F & Lalmohamed, A 2021, ' Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls ', Rheumatology (United Kingdom), vol. 60, no. 1, pp. 207-216 . https://doi.org/10.1093/rheumatology/keaa267
Bultink, IEM, de Vries, F, van Vollenhoven, RF & Lalmohamed, A 2020, ' Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls ', Rheumatology (Oxford, England), vol. 60, pp. 207-216 . https://doi.org/10.1093/rheumatologt/keaa267
Rheumatology (United Kingdom), 60(1), 207-216. Oxford University Press
Rheumatology (Oxford, England), 60, 207-216. Oxford University Press
Rheumatology, 60(1), 207-216. Oxford University Press
Rheumatology (Oxford, England), 60(1), 207. Oxford University Press
Bultink, I E M, de Vries, F, van Vollenhoven, R F & Lalmohamed, A 2021, ' Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls ', Rheumatology (United Kingdom), vol. 60, no. 1, pp. 207-216 . https://doi.org/10.1093/rheumatology/keaa267
Objectives We wanted to estimate the magnitude of the risk from all-cause, cause-specific and sex-specific mortality in patients with SLE and relative risks compared with matched controls and to evaluate the influence of exposure to medication on ris
Autor:
Althunian, Turki A., de Boer, Anthonius, Groenwold, Rolf H.H., Rengerink, Katrien O., Souverein, Patrick C., Klungel, Olaf H., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety, 29(10), 1263. John Wiley and Sons Ltd
Pharmacoepidemiology and Drug Safety, 29(10), 1263. John Wiley and Sons Ltd
Purpose To compare the effectiveness and safety of a drug in daily practice with the outcomes of a target non‐inferiority trial by rigorously mimickingin an observational study the trial's design features. Methods This cohort study was conducted us
Autor:
Zazuli, Zulfan, Jong, Corine de de, Xu, Wei, Vijverberg, Susanne J. H., Masereeuw, Rosalinde, Patel, Devalben, Mirshams, Maryam, Khan, Khaleeq, Cheng, Dangxiao, Ordonez-Perez, Bayardo, Huang, Shao Hui, Spreafico, Anna, Hansen, Aaron R., Goldstein, David P., Almeida, John R. de de, Bratman, Scott V., Hope, Andrew, Knox, Jennifer J., Wong, Rebecca K. S., Darling, Gail E., Kitchlu, Abhijat, Haarlem, Simone W. A. van van, Meer, Femke van der, Lindert, Anne S. R. van, Heuvel, Alexandra ten ten, Brouwer, Jan, Ross, Colin J. D., Carleton, Bruce C., Egberts, Toine C. G., Herder, Gerarda J. M., Deneer, Vera H. M., Zee, Anke H. Maitland-van der, Liu, Geoffrey, Afd Pharmacology, Afd Pharmacoepi & Clinical Pharmacology, Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 1233, p 1233 (2021)
Journal of Personalized Medicine, 11(11), 1. Multidisciplinary Digital Publishing Institute (MDPI)
Volume 11
Issue 11
Journal of Personalized Medicine, 11(11):1233. MDPI Multidisciplinary Digital Publishing Institute
Journal of Personalized Medicine, Vol 11, Iss 1233, p 1233 (2021)
Journal of Personalized Medicine, 11(11), 1. Multidisciplinary Digital Publishing Institute (MDPI)
Volume 11
Issue 11
Journal of Personalized Medicine, 11(11):1233. MDPI Multidisciplinary Digital Publishing Institute
This study aims to evaluate genetic risk factors for cisplatin-induced nephrotoxicity by investigating not previously studied genetic risk variants and further examining previously reported genetic associations. A genome-wide study (GWAS) was conduct
Autor:
Bloem, Lourens T., Vreman, Rick A., Peeters, Niels W.L., Hoekman, Jarno, van der Elst, Menno E., Leufkens, Hubert G.M., Klungel, Olaf H., Goettsch, Wim G., Mantel-Teeuwisse, Aukje K., Afd Pharmacoepi & Clinical Pharmacology, Innovation and Sustainability, Innovation Studies, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Bloem, L T, Vreman, R A, Peeters, N W L, Hoekman, J, van der Elst, M E, Leufkens, H G M, Klungel, O H, Goettsch, W G & Mantel-Teeuwisse, A K 2021, ' Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies ', Clinical and Translational Science, vol. 14, no. 4, pp. 1566-1577 . https://doi.org/10.1111/cts.13027
Clinical and Translational Science
Clinical and Translational Science, 14(4), 1566. Wiley-Blackwell Publishing Ltd
Clinical and Translational Science, Vol 14, Iss 4, Pp 1566-1577 (2021)
Clinical and Translational Science
Clinical and Translational Science, 14(4), 1566. Wiley-Blackwell Publishing Ltd
Clinical and Translational Science, Vol 14, Iss 4, Pp 1566-1577 (2021)
We aimed to determine whether uncertainties identified by the European Medicines Agency (EMA) were associated with negative relative effectiveness assessments (REAs) and negative overall reimbursement recommendations by national health technology ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a71acd97b023da84d700690233e35581
https://dspace.library.uu.nl/handle/1874/412025
https://dspace.library.uu.nl/handle/1874/412025
Autor:
Houghton, Richard, de Vries, Frank, Loss, Georg, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Cns Drugs, 34(1), 93-101. Adis International Ltd
CNS Drugs, 34. Adis International Ltd
CNS Drugs
CNS Drugs, 34. Adis International Ltd
CNS Drugs
Background Psychostimulants and atomoxetine have been shown to increase blood pressure, heart rate, and QT interval in children and adolescents; however, based on current literature, it is unclear if these “attention-deficit/hyperactivity disorder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b6f33a338128c8f287ab86d1df537b4
https://cris.maastrichtuniversity.nl/en/publications/0120fb72-b721-4cc3-8136-caa9a464054a
https://cris.maastrichtuniversity.nl/en/publications/0120fb72-b721-4cc3-8136-caa9a464054a
Autor:
Vreman, Rick A., Mantel-Teeuwisse, Aukje K., Hövels, Anke M., Leufkens, Hubert G.M., Goettsch, Wim G., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Value in Health, 23(1), 10. Elsevier Ltd
Background: Health technology assessment (HTA) plays an important role in reimbursement decision-making in many countries, but recommendations vary widely throughout jurisdictions, even for the same drug. This variation may be due to differences in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f62287db58bf532165145ca12042d8
https://dspace.library.uu.nl/handle/1874/410897
https://dspace.library.uu.nl/handle/1874/410897
Autor:
van Strien, Astrid M, Souverein, Patrick C, Keijsers, Carolina J P W, Heerdink, Eibert R, Derijks, Hieronymus J, van Marum, Rob J, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Journal of Clinical Psychopharmacology, 38(4), 296. Lippincott Williams and Wilkins
van Strien, A M, Souverein, P C, Keijsers, C J P W, Heerdink, E R, Derijks, H J & van Marum, R J 2018, ' Association between Urinary Tract Infections and Antipsychotic Drug Use in Older Adults ', Journal of Clinical Psychopharmacology, vol. 38, no. 4, pp. 296-301 . https://doi.org/10.1097/JCP.0000000000000895
Journal of Clinical Psychopharmacology, 38(4), 296-301. Lippincott Williams and Wilkins
van Strien, A M, Souverein, P C, Keijsers, C J P W, Heerdink, E R, Derijks, H J & van Marum, R J 2018, ' Association between Urinary Tract Infections and Antipsychotic Drug Use in Older Adults ', Journal of Clinical Psychopharmacology, vol. 38, no. 4, pp. 296-301 . https://doi.org/10.1097/JCP.0000000000000895
Journal of Clinical Psychopharmacology, 38(4), 296-301. Lippincott Williams and Wilkins
Background Antipsychotic drugs are frequently prescribed to older adults, but they may be associated with serious adverse effects. The objective was to investigate the association between use of antipsychotics in older adults and the risk of urinary
Autor:
Torre, Carla, Guerreiro, José, Longo, Patrícia, Raposo, João Filipe, Leufkens, Hubert, Martins, Ana Paula, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Patient preference and adherence
Patient Preference and Adherence, 12, 1471. Dove Medical Press Ltd.
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Patient preference and adherence
Patient Preference and Adherence, 12, 1471. Dove Medical Press Ltd.
Carla Torre,1,2 José Guerreiro,1 Patrícia Longo,1 João Filipe Raposo,3,4 Hubert Leufkens,5 Ana Paula Martins2,6 1Centre for Health Evaluation& Research (CEFAR), National Association of Pharmacies, Lisboa, Portugal; 2Research Institute for Medicine
Autor:
Janssen, Paul W.A., Bergmeijer, Thomas O., Vos, Gert Jan A., Kelder, Johannes C., Qaderdan, Khalid, Godschalk, Thea C., Breet, Nicoline J., Deneer, Vera H.M., Hackeng, Christian M., ten Berg, Jurriën M., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
European Journal of Clinical Pharmacology, 75(9), 1201. Springer
European Journal of Clinical Pharmacology, 75(9), 1201. Springer Verlag
European Journal of Clinical Pharmacology, 75(9), 1201. Springer Verlag
PURPOSE: The POPular Risk Score was developed for the selective intensification of P2Y 12 inhibitor treatment with prasugrel instead of clopidogrel in patients undergoing non-urgent percutaneous coronary intervention (PCI) with stent implantation. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d211269ebfd09dbd8272d71fe64ec7b
https://dspace.library.uu.nl/handle/1874/391926
https://dspace.library.uu.nl/handle/1874/391926